Relationship between markers of inflammation and hemodynamic stress and death in patients with out-of-hospital cardiac arrest.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 05 2021
Historique:
received: 23 12 2020
accepted: 12 04 2021
entrez: 12 5 2021
pubmed: 13 5 2021
medline: 9 11 2021
Statut: epublish

Résumé

Biomarkers that reflect hemodynamic stress, inflammation, extracellular matrix remodeling, angiogenesis, and endothelial dysfunction may improve risk stratification and add valuable pathobiological insight in patients with out-of-hospital cardiac arrest (OHCA). In total, 120 patients with OHCA who survived at least 48 h after return of spontaneous circulation were consecutively included in the present analysis. Concentrations of 30 biomarkers were measured simultaneously using a multi-panel biomarker assay. Cox regression models were adjusted for age, sex, estimated glomerular filtration rate, lactate concentration, bystander resuscitation, initial cardiac rhythm, and type of targeted temperature management. Overall, 57 patients (47.5%) had a favorable neurological outcome (Cerebral Performance Category ≤ 2) at 30 days, while palliative care was initiated in 49 patients (40.8%), and 52 patients (43.3%) died. After correction for multiple testing with Bonferroni-Holm, 8 biomarkers (including Angiopoietin-2, Procalcitonin, Resistin, IL-4Rα, MMP-8, TNFα, Renin, and IL-1α) were significantly associated with all-cause death. After multivariable adjustment, only angiopoietin-2 (Adjusted (Adj) hazard ratio (HR) per 1-unit increase in standardized biomarker concentrations 1.52 (95% CI 1.16-1.99)) and renin (Adj HR 1.32 (95% CI 1.06-1.65) remained independently associated with an increased risk of death. The discriminatory performance indicated good performance for angiopoietin-2 (area under the curve (AUC): 0.75 (95% CI 0.66-0.75) and was significantly higher (P = 0.011) as compared with renin (AUC: 0.60, 95% CI 0.50-0.60). In conclusion, angiopoietin-2 was significantly associated with all-cause mortality in patients with OHCA who survived the first 48 h and may prove to be useful for risk stratification of these patients.

Identifiants

pubmed: 33976254
doi: 10.1038/s41598-021-88474-3
pii: 10.1038/s41598-021-88474-3
pmc: PMC8113496
doi:

Substances chimiques

Angiopoietin-2 0
Biomarkers 0
Renin EC 3.4.23.15

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9954

Références

Comput Math Methods Med. 2013;2013:745742
pubmed: 24454541
Control Clin Trials. 1996 Aug;17(4):343-6
pubmed: 8889347
Clin Res Cardiol. 2015 May;104(5):380-7
pubmed: 25408112
ERJ Open Res. 2015 Oct 19;1(2):
pubmed: 27730146
N Engl J Med. 2002 Feb 21;346(8):549-56
pubmed: 11856793
Blood. 2004 Jun 1;103(11):4150-6
pubmed: 14976056
Eur Heart J Acute Cardiovasc Care. 2020 Nov;9(4_suppl):S169-S174
pubmed: 30449136
Resuscitation. 2016 Jan;98:91-6
pubmed: 26655587
Nat Rev Cardiol. 2019 Jul;16(7):407-416
pubmed: 30858511
Eur J Heart Fail. 2015 Nov;17(11):1152-60
pubmed: 26333723
Curr Opin Hematol. 2017 Sep;24(5):432-438
pubmed: 28582314
Intensive Care Med. 2018 Nov;44(11):1849-1858
pubmed: 30343317
Crit Care Med. 2011 Apr;39(4):702-10
pubmed: 21242795
Nat Med. 2006 Feb;12(2):235-9
pubmed: 16462802
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Eur Heart J. 2013 Jun;34(22):1651-62
pubmed: 23349297
Ann Emerg Med. 2014 Nov;64(5):496-506.e1
pubmed: 25064741
Resuscitation. 2008 Dec;79(3):350-79
pubmed: 18963350

Auteurs

Thomas A Zelniker (TA)

Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, Austria.

Ziya Kaya (Z)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.

Eva Gamerdinger (E)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.

Sebastian Spaich (S)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Department of Cardiology, Robert-Bosch-Hospital, Stuttgart, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.

Jan Stiepak (J)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.

Evangelos Giannitsis (E)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.

Hugo A Katus (HA)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.

Michael R Preusch (MR)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. Michael.preusch@med.uni-heidelberg.de.
German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany. Michael.preusch@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH